Prasol Chemicals Ltd IPO: issue details, subscription, GMP trend and listing outcome

Prasol Chemicals Ltd, an Indian specialty chemicals manufacturer, launched a mainboard initial public offering (IPO) of ₹500 crore at a price band of ₹643 to ₹676 per share. The issue opened on 08 September 2026 and closed on 10 September 2026. The IPO comprised a ₹80 crore fresh issue (proceeds to the company) and a ₹420 crore offer for sale (OFS) by certain existing shareholders (proceeds to selling shareholders). The equity shares were listed on NSE and BSE on 16 September 2026 at ₹611, as per the snapshot.

Business overview: specialty derivatives across multiple end-use industries

Prasol Chemicals Ltd describes itself as a specialty chemicals manufacturer with more than three decades of operating history. The company manufactures acetone-based and phosphorus-based specialty derivatives along with other customized specialty chemicals. It reports a portfolio of more than 150 products, supplying to more than 1,600 customers.

The stated end-use industries include agrochemicals, pharmaceuticals, home and personal care, paints/inks/construction/adhesives (PICA), and performance chemicals. Alongside domestic sales, the company exports to dozens of countries. It also cites the creation of a stock point in Rotterdam in 2024 to improve service to European customers, indicating a distribution step aimed at export markets.

Manufacturing facilities referenced in the supplied context are located in Maharashtra, including sites in Khopoli and Mahad. The IPO description also frames the listing as a capital markets step alongside ongoing capacity debottlenecking and expansion, and research and development (R&D)-led product development.

Key milestones and footprint expansion

The company’s disclosed milestones map a gradual expansion of product families and end-market participation. Prasol Chemicals was incorporated in 1992 and diversified into phosphorous-based products by 1996 for agrochemicals and performance chemicals. It then built an organic-technology platform in 2003 and entered home and personal care.

Further segment additions included entry into the pharmaceutical segment with phosphorous-based products in 2007 and the launch of new acetone derivatives in 2009. The company also cites entry into antibiotics and antiwear industry for lubricants in 2011.

On the asset and site development side, the timeline includes acquiring land in Saykha Industrial Area, Gujarat (2015) and Mahad, Maharashtra (2017), both on a leave and licence basis. It established a cogeneration power plant at Khopoli in 2019 and commissioned the Mahad site for agrochemical intermediates in 2020. More recently, it launched a construction chemicals portfolio in 2022, expanded agrochemical advanced intermediates in 2023, and launched a mining chemicals portfolio in 2025.

IPO structure, allocation and timeline

Prasol Chemicals Ltd came to the market with a ₹500 crore book-built IPO, with a price band of ₹643 to ₹676 per share and a lot size of 22 shares.

The issue size was split between:

• Fresh issue of ₹80 crore, where the net proceeds are intended for the company’s stated objects
• Offer for sale of ₹420 crore by certain existing shareholders, where proceeds are received by selling shareholders

The disclosed schedule shows the IPO opening on 08 September 2026 and closing on 10 September 2026, with allotment dated 11 September 2026, refunds dated 15 September 2026, and listing dated 16 September 2026.

For category allocation, the snapshot provides a reservation split of 50% for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors (NII), and 35% for Retail Individual Investors. The context also provides anchor allocation mechanics within the QIB portion, including that the anchor portion is stated as 60% of the QIB allocation and that a 33.33% reservation for domestic mutual funds applies within the anchor book, as disclosed.

The IPO description notes that the company has incurred IPO-related expenses, including those related to an earlier lapsed IPO attempt and a renewed filing with Securities and Exchange Board of India (SEBI) observations, and that it intends to adjust eligible offer expenses against securities premium upon completion.

Subscription, GMP observations and listing outcome

At the close of the book, overall subscription was recorded at 0.76 times. By category, the snapshot shows Retail Individual Investors subscribed at 1.19 times, Non-Institutional Investors at 0.69 times, and Qualified Institutional Buyers at 0.06 times.

The supplied grey market premium (GMP) observations, an unofficial indicator, cover ten dated points from 10 September 2026 to 16 September 2026, referenced to an issue price of ₹676. Across these observations, GMP ranged from ₹4 to ₹-15, with the latest observation at ₹-13 on 16 September 2026.

On listing, the shares debuted on 16 September 2026 at ₹611, which corresponds to a -9.62% listing gain/loss versus the upper price band reference in the snapshot.

Financial trajectory and disclosed KPIs

Across FY2024 to FY2026 in the supplied financials, Prasol Chemicals reported an increase in total revenue from ₹876.57 crore to ₹1,232.59 crore, while profit after tax (PAT) rose from ₹18.13 crore to ₹83.12 crore. Over the same period, the reported PAT margin increased to 6.74% in FY2026, and total assets increased from ₹626.36 crore to ₹839.28 crore.

For operating and return metrics provided in the snapshot, the company reports an EPS of ₹14.33. Returns are shown as return on equity (ROE) of 20.37%, return on capital employed (ROCE) of 22.43%, and return on net worth (RoNW) of 18.53%. The snapshot also discloses an EBITDA margin of 11.30% and a debt-to-equity ratio of 0.19.

For valuation context in the same dataset, price-to-book is provided at 8.75 times. The snapshot lists pre-IPO price-to-earnings (P/E) as 0, indicating that a P/E multiple is not presented in the supplied fields in a usable form for comparison within this article.

Proposed use of fresh issue proceeds, and key risks to track

The company’s stated objects of the issue are:

• Repayment and/or pre-payment, in full or part, of certain borrowings availed by the company
• General corporate purposes

In the supplied use-of-funds fields, the prospectus objectives are presented with proposed allocations of ₹60 crore for repayment/prepayment of borrowings and ₹69 crore for general corporate purposes, while the fresh issue size is ₹80 crore. As a structural point for readers, only the fresh issue proceeds accrue to Prasol Chemicals, whereas OFS proceeds go to selling shareholders.

The risk-related narrative in the snapshot highlights operating, supply chain, and policy sensitivities. It references a prior shutdown at the Mahad plant due to a gas leak and flags that any repeat safety issue could disrupt production, add compliance costs, and affect customer trust. The snapshot also notes that the company imports a large share of raw materials, which may expose it to supply delays or cost spikes. In addition, it references changes and temporary withdrawal for some routes in RoDTEP (Remission of Duties and Taxes on Exported Products), indicating policy variability that may affect export incentives and cash flows.

Monitoring points, based on the supplied disclosures, are:

• Continuity and safety performance at the Mahad facility, given the prior shutdown reference.
• Movement in raw material sourcing conditions and import-linked supply timelines, given the stated import dependence.
• Any change in export-linked incentive and tax mechanisms mentioned in the snapshot, including RoDTEP-related policy changes.
• The company’s execution on the stated objects of the fresh issue, including repayment/prepayment of certain borrowings and general corporate purposes.

Complete numeric snapshot

IPO terms and schedule

Key performance indicators and valuation

Category reservations and anchor allocation

Proposed use of fresh issue proceeds

Subscription status (19 Sep 2026)

Grey market premium (GMP) trend

GMP is an unofficial market indicator and can change; these are dated snapshot observations, not a listing forecast.